Saving Lives Past the Emergency Room

For people who have suffered a massive traumatic injury--from a car crash, building collapse, or other life-threatening event--modern health care is paradoxical in nature. While the emergency room is successful in prolonging lives, it is the body's system failures that eventually kill trauma patients. "If you look at the successes that medicine has had in our ability to capture individuals immediately after trauma, to resuscitate them, get them to the emergency room, we've been remarkably succes

Written byHarvey Black
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Also known as multi-organ dysfunction syndrome, this gradual, then hasty, cessation of vital organs is a major cause of posttraumatic event death. The reasons are obscure. "We really don't have a clue," says J. Perren Cobb, a surgery professor at Washington University in St. Louis. An attempt to grasp the nature of the problem and improve the situation came this past October when a $25 million, five-year grant was awarded from the National Institute of General Medical Sciences. The research involves 500 patients and some 45 investigators at 20 centers. This so-called glue grant, because it brings together scientists from a large number of institutions, is focused on understanding inflammation by using the knowledge and techniques spawned by human genome research.

The body's inflammatory response, says Timothy Buchman, a surgery professor at Washington University, is designed to control pathogens and remove damaged tissue from wounds. "These inflammatory molecules were designed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies